The introduction of smart bioactive wound dressing is likely to bring enormous business opportunities to the vendors
The global bioactive wound care market is growing at a healthier rate and is expected to grow at a CAGR of 6% during the forecast period. The increasing demand for innovative, effective, and proficient wound care products from surgeons as well as patients is expected to promote the market. With the availability of positive clinical evidences, demonstrating the superiority of newly launched advanced products, end-users are expected to adopt them as an alternative to other conventional products increasingly.
The growing incidence of chronic infection, including pressure ulcers, diabetic foot ulcers, venous ulcers as well as injuries related to burn, trauma, accidents, and surgery, is likely to increase the demand for innovative products. Favorable patient demographics is further driving manufacturers continue to launch new products. Another factor promoting development is their improved healing capacity and better clinical outcomes. In terms of geography, North America is leading, followed by Europe, APAC, Latin America, and MEA. The high growth of North America region can be attributed to the growing patient population suffering from acute and chronic infections due to the rise in lifestyle-related diseases such as diabetes.
The introduction of smart bioactive dressing is likely to bring exciting business opportunities for the vendors. Recent developments in the dressings with micro-fibers and biosensing for smart wound dressing enable quantitative, real-time representation of the wound environment, including pathogen concentrations, exudate levels, and tissue regeneration are likely to influence the market significantly.
BIOACTIVE WOUND CARE MARKET SEGMENTATION
This research report includes detailed segmentation by products, wound type, end-users, and geography.
INSIGHTS BY PRODUCTS
The growing wound management cost and the increasing population size with acute and chronic infections are increasing the demand for alginate dressings
The antimicrobial dressings segment is growing due to the high prevalence of several chronic infections. The high demand for these dressings is leading to the introduction of a broad range of dressing offerings, which, in turn, are boosting the segment. Moreover, key vendors are focusing on several clinical trials to increase the efficacy of these dressings, thereby increasing market opportunities.
Wound biologics is the second largest segment of the bioactive wound care market. The segment is growing primarily due to the rising incidence of DFUs, venous ulcers, burn injuries, trauma, surgical site infections, and other accidental injuries globally. The increasing wound management cost and the increasing population size with various acute and chronic infections are increasing the demand for alginate dressings. Further, a wide range of commercially available alginate dressings is also driving the growth. Recently, several key players have offered silver-impregnated alginate dressings to treat the infections.
INSIGHTS BY WOUND TYPE
The phenomenal growth in surgical site infections is a key factor for the growth of the acute wound care segment
The bioactive wound care market is growing mainly on account of the rise in surgical procedures due to the growing incidence of chronic diseases. According to the WHO, approximately 234·2 million major surgical procedures are performed globally every year. The rise in surgical procedures, especially in the geriatric population, which also suffer from several acute and chronic diseases worldwide, is projected to influence the acute bioactive wound care segment. The phenomenal growth in the surgical site infections is another key factor for the growth of the segment. Furthermore, the number of burn cases is also increasing globally over the years. Therefore, the growing incidence of acute wounds and associated infections is fueling the growth of the segment.
INSIGHTS BY END-USERS
The application of several wound care products in home healthcare settings is expected to increase steadily during the forecast period
In 2018, the hospital & specialty care clinic segment was the leading end-user segment. The bioactive wound care market shares are growing mainly due to the increasing prevalence of acute infections, the growing number of surgical procedures, the increasing awareness of advanced products, and increasing number treatments being conducted in hospitals.
The long-term care facility segment is growing at a steady pace. The rise in incidences of chronic infections is growing due to the increasing patient population with lifestyle diseases such as diabetes. The growing elderly population is also contributing to the growth of the segment.
The home healthcare segment is witnessing the fastest CAGR in all other end-user segments. This segment is expected to increase steadily during the forecast period as the cost of hospital stay has significantly increased. Many vendors are also increasingly developing bioactive wound care products with features such as portability, ease of use, and low costs. The introduction of these features is likely to increase the adoption of in home healthcare settings.
INSIGHTS BY GEOGRAPHY
The increase in R&D for the development of innovative products will have a positive impact on the North American market
In 2018, North America was the largest region of the global bioactive wound care market. The growing population suffering from several acute and chronic infections is the primary factor for the high share. Europe is the second-largest market and the growth is on account of highly sophisticated healthcare infrastructure, the patient population with high awareness of bioactive wound care.
APAC is the fastest-growing market. The growing awareness of available treatment options and the increasing aging population are the major factors driving the growth. Favorable government initiatives and improved healthcare infrastructure are further driving the growth in the APAC region. Brazil, Mexico, and Argentina are the major revenue contributors in Latin America region. The growing incidence of several disease-related infections and the high prevalence of surgical infections are major drivers of the market.
Turkey, South Africa, Saudi Arabia, and Iran are the major revenue contributors to the MEA market. The market is growing due to the growing frequency of acute infections in the patient population with chronic diseases, high healthcare expenditure, and a large middle-class population with high spending power.
KEY VENDOR ANALYSIS
The global bioactive wound care market is highly competitive and dynamic, characterized by the presence of many global, regional, and local vendors offering a diverse range of products for treating various acute and chronic infections. Approximately more than 300 vendors are offering a wide array of products worldwide. Multiple product launches, strategic acquisitions, and diversified product portfolio fueled their growth in recent years. New product launches and strategic acquisitions, collaborations, will be crucial for companies to maintain revenue growth in the coming years.
- Mölnlycke Health Care
- PAUL HARTMANN
- Smith & Nephew
The bioactive wound care market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
- Antimicrobial Dressings
- Wound Care Dressings
- Hydrocolloid Dressings
- Alginate Dressings
- Collagen Dressings
By Wound Type
- Hospitals and Specialty Care Clinics
- Long-term Care Facilities
- Home Healthcare
- Others (ASCs, solo practitioners, and other acute care settings)
- North America
- South Korea
- Latin America
- Saudi Arabia
- South Africa